Capitol Health Limited (AU:CAJ) has released an update.
Capitol Health Limited has announced a potential merger with Integral Diagnostics, offering Capitol shareholders a 33% premium on the last close share price and promising enhanced scale, improved clinical outcomes, and significant financial benefits, including at least $10 million in anticipated annual pre-tax net cost synergies. The merger is proposed through a scheme of arrangement, with Capitol Health’s Justin Walter highlighting the opportunity for growth and value creation for shareholders, radiologists, technicians, and staff. The completion of the merger is subject to customary conditions, including shareholder and court approvals and ACCC clearance.
For further insights into AU:CAJ stock, check out TipRanks’ Stock Analysis page.